Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2002-4-8
pubmed:abstractText
We demonstrate the absolute requirement for a functioning class II-restricted Ag processing pathway in the CNS for the initiation of experimental autoimmune encephalomyelitis (EAE). C57BL/6 (B6) mice deficient for the class II transactivator, which have defects in MHC class II, invariant chain (Ii), and H-2M (DM) expression, are resistant to initiation of myelin oligodendrocyte protein (MOG) peptide, MOG(35-55)-specific EAE by both priming and adoptive transfer of encephalitogenic T cells. However, class II transactivator-deficient mice can prime a suboptimal myelin-specific CD4(+) Th1 response. Further, B6 mice individually deficient for Ii and DM are also resistant to initiation of both active and adoptive EAE. Although both Ii-deficient and DM-deficient APCs can present MOG peptide to CD4(+) T cells, neither is capable of processing and presenting the encephalitogenic peptide of intact MOG protein. This phenotype is not Ag-specific, as DM- and Ii-deficient mice are also resistant to initiation of EAE by proteolipid protein peptide PLP(178-191). Remarkably, DM-deficient mice can prime a potent peripheral Th1 response to MOG(35-55), comparable to the response seen in wild-type mice, yet maintain resistance to EAE initiation. Most striking is the demonstration that T cells from MOG(35-55)-primed DM knockout mice can adoptively transfer EAE to wild-type, but not DM-deficient, mice. Together, these data demonstrate that the inability to process antigenic peptide from intact myelin protein results in resistance to EAE and that de novo processing and presentation of myelin Ags in the CNS is absolutely required for the initiation of autoimmune demyelinating disease.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation..., http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/H2-M antigens, http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II, http://linkedlifedata.com/resource/pubmed/chemical/MHC class II transactivator protein, http://linkedlifedata.com/resource/pubmed/chemical/Myelin Proteolipid Protein, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators, http://linkedlifedata.com/resource/pubmed/chemical/invariant chain, http://linkedlifedata.com/resource/pubmed/chemical/myelin oligodendrocyte..., http://linkedlifedata.com/resource/pubmed/chemical/myelin proteolipid protein (178-191)
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
168
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4173-83
pubmed:dateRevised
2011-8-26
pubmed:meshHeading
pubmed-meshheading:11937578-Adoptive Transfer, pubmed-meshheading:11937578-Amino Acid Sequence, pubmed-meshheading:11937578-Animals, pubmed-meshheading:11937578-Antigen Presentation, pubmed-meshheading:11937578-Antigens, Differentiation, B-Lymphocyte, pubmed-meshheading:11937578-Cell Movement, pubmed-meshheading:11937578-Central Nervous System, pubmed-meshheading:11937578-Encephalomyelitis, Autoimmune, Experimental, pubmed-meshheading:11937578-Epitopes, T-Lymphocyte, pubmed-meshheading:11937578-Female, pubmed-meshheading:11937578-Glycoproteins, pubmed-meshheading:11937578-Histocompatibility Antigens Class II, pubmed-meshheading:11937578-Immunity, Innate, pubmed-meshheading:11937578-Injections, Subcutaneous, pubmed-meshheading:11937578-Lymphocyte Activation, pubmed-meshheading:11937578-Male, pubmed-meshheading:11937578-Mice, pubmed-meshheading:11937578-Mice, Inbred C57BL, pubmed-meshheading:11937578-Mice, Knockout, pubmed-meshheading:11937578-Molecular Sequence Data, pubmed-meshheading:11937578-Myelin Proteolipid Protein, pubmed-meshheading:11937578-Nuclear Proteins, pubmed-meshheading:11937578-Peptide Fragments, pubmed-meshheading:11937578-Th1 Cells, pubmed-meshheading:11937578-Trans-Activators
pubmed:year
2002
pubmed:articleTitle
De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
pubmed:affiliation
Department of Microbiology-Immunology and Pathology, Northwestern University Medical School, Chicago, IL 60611, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't